Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
The conclave brought together over 1,000 delegates from across India and internationally
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
Subscribe To Our Newsletter & Stay Updated
